ArticleBiological trace element research2026
Identification of Nuclearity of Chromium Binary Adducts with DNA by Negative Ion Mass Spectrometry: Short Communication.
Article in Biological trace element research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Reassessing the Significance of Chromium-DNA Adducts in Chromate Carcinogenicity.Biological trace element research · 2026Review
- Post-pubertal Susceptibility to Cadmium-Induced Cardiac Injury: Role of Metallothionein, Antioxidant Defense, and Endocrine Modulation.Cardiovascular toxicology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Chromium(VI) is a carcinogen and mutagen, and its mechanism of action is proposed to involve binding of its reduction product, chromium(III), to DNA. Recently, this laboratory has shown that small oligonucleotide duplexes of DNA can be used to generate binary adducts of Cr(III). The structure of the Cr(III) binding site on the duplex DNA can be established using a combination of paramagnetic NMR, EPR, and FTIR spectroscopies. These studies have shown that aquated mononuclear Cr(III) or aquated hydroxo-bridged binuclear Cr(III) moieties bind to N-7 of guanine residues of the DNA depending on the DNA sequence. In the past determining which of these binary adducts formed required time-consuming variable temperature magnetic susceptibility and related experiments. Negative ion mass spectrometry (MS) can be utilized to efficiently identify whether mononuclear or binuclear binary Cr(III) adducts are formed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.